Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.

Published 5 سال قبل on جون 5 2021، 6:33 صبح
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters

In Yemen's Aden, divided government forces prepare for a Houthi assault
- 16 hours ago

Canva adds an AI ‘off’ button
- an hour ago

ChatGPT can transcribe as you speak now with Live Dictation
- an hour ago

What makes Americans feel financially ready to have kids? It’s complicated.
- 8 hours ago

FCC greenlights rule allowing prisons to jam cellphone signals
- an hour ago

Oh, Elon Musk is ‘moderate’ now, is he?
- an hour ago

NationalGrid plans Rs100bn Sukuk programme to strengthen Pakistan’s electricity transmission network
- 21 hours ago

CDF munir vows to eliminate menace of terrorism in KP
- a day ago

Gold prices record visible decline in Pakistan, global markets
- 20 hours ago

Trump’s looming nominations crunch
- a day ago

Scoop up three great 4K Blu-ray movies for $33
- 10 hours ago

Pakistan clinches Blind T20 Asia Cup title in Dhaka
- 18 hours ago
You May Like
Trending
















